High levels of interleukin-6 in the exhaled breath condensate of patients with COPD
Open Access
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 97 (12), 1299-1302
- https://doi.org/10.1016/j.rmed.2003.07.008
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Exhaled Markers of Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Increased Levels of Interleukin-6 Are Associated with Lymphocytosis in Bronchoalveolar Lavage Fluids of Idiopathic Nonspecific Interstitial PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancerJournal of Laboratory and Clinical Medicine, 1999
- Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPDRespiratory Medicine, 1998
- Nebulizer therapy. Guidelines. British Thoracic Society Nebulizer Project GroupThorax, 1997
- Statistics Notes: Measurement errorBMJ, 1996
- Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.American Journal of Respiratory and Critical Care Medicine, 1996
- Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseasesClinical and Experimental Immunology, 1995
- Carbon Dioxide and Oxygen Partial Pressure in Expiratory Water Condensate Are Equivalent to Mixed Expired Carbon Dioxide and OxygenChest, 1992